Weather Operations Update – January 26, 2026
Due to weather conditions, PET Imaging locations will operate as follows:
Tulsa will be closed today (January 26, 2026) due to weather conditions.
The Woodlands and Sugar Land plan to open at 12:00 PM CST today.
We will continue to monitor conditions and provide updates if hours change. Please stay safe.
A PET/CT scan that uses PSMA tracer can help identify prostate cancer. The radioactive PSMA tracer is injected by IV (intravenously), and attaches to prostate cancer cells, both in the prostate, as well as in metastases. Once it has attached to the cells, it sends out signals that are picked up by the PET/CT scanner, allowing it to form a picture of the location of any prostate cancer that might be present in the body. This provides more accurate and earlier detection of prostate cancer, helping doctors and patients make better-informed treatment decisions.
As with all cancers, an important part of the treatment process is detecting the cancer as early as possible. PET Imaging now offers a PSMA PET/CT scan. PSMA is used for men with prostate cancer:
PSMA scans are able to detect cancer that is located in:
Some added benefits to using PSMA tracers with PET/CT scans include being minimally invasive and often replacing the need for surgical biopsies, it’s ability to locate very small tumors more accurately compared to other tests, and it’s ability focus on prostate cancer by targeting PSMA protein, which is found on the surface of more than 90% of prostate cancer cells. There is a added risk of the small amount of radiation with the scan. Excessive radiation can increase the risk for cancer, however the small amount of radiation received from this scan alone has been determined to be unlikely to cause cancer. During your consultation, our medical team will recommend this test only if it is determined to be of benefit to you in finding prostate cancer. If you are interested in getting a PSMA scan, please fill out our form, and one of our team members will contact you to set up an appointment.
The prostate is a small walnut-shaped gland in males that uses male hormones called androgens, such as testosterone and dihydrotestosterone (DHT), to trigger and maintain male sex characteristics and reproduction. Prostate cancer begins when cells in the prostate gland start to grow out of control.
Other than skin cancer, prostate cancer is the most common cancer in American men. According to the American Cancer Society (ACS), about one man in nine will be diagnosed with prostate cancer during his lifetime.
In many cases, prostate cancer is a slow-growing cancer that does not spread beyond the prostate gland before the time of diagnosis. However, some cases are more aggressive and need more urgent treatment. Prostate cancer that is detected early, when it is still confined to the prostate gland, has the best chance for successful treatment.
Researchers have found several factors that might affect a man’s risk of getting prostate cancer, including:
Because these symptoms may overlap with those of other conditions, it is important to get the correct diagnosis to find the right treatment. To help determine the best option for you the American Cancer Society recommends prostate screenings.
An integrated PET/CT scan is one of the most advanced imaging technologies for the detection and evaluation of cancer. A PET/CT scan provides images of the entire body and generates high-resolution images of abnormal activity and its location. Abnormal activity often takes place before physical changes are identifiable by other types of imaging such as MRI, CT, x-ray and ultrasound. The scan can detects primary and secondary disease earlier and more accurately than other imaging technologies. Before having a PET scan, your doctor may order a series of x-rays, MRIs or CTs. Our team will work with your doctor and insurance payer to determine which test is most appropriate based on your diagnosis and symptoms.